Author
Listed:
- Ushma Mehta
(University of Cape Town)
- Mariette Smith
(University of Cape Town
Provincial Government of the Western Cape)
- Emma Kalk
(University of Cape Town)
- Helen Hayes
(Provincial Government of the Western Cape)
- Annoesjka Swart
(University of Cape Town)
- Lawrence Tucker
(University of Cape Town)
- Renier Coetzee
(University of the Western Cape)
- Andrew Boulle
(University of Cape Town
Provincial Government of the Western Cape)
- Marc Blockman
(University of Cape Town)
Abstract
Introduction Growing evidence of the teratogenic potential of sodium valproate (VPA) has changed prescribing practices across the globe; however, the impact of this research and the consequent dissemination of a Dear Health Care Professional Letter (DHCPL) in December 2015, recommending avoidance of the teratogen VPA in women of childbearing age (WOCBA) and pregnant women in South Africa, is unknown. We explored trends and reasons for VPA use among pregnant women and WOCBA in the public sector in Western Cape Province from 1 January 2015 to 31 December 2017. Methods Using the provincial health information exchange that collates routine electronic health data via unique patient identifiers, we analysed clinical and pharmacy records from 2015 to 2017 to determine prescription patterns of VPA and other antiepileptic drug (AED) and mood-stabilising medicine (MSM) use in WOCBA and pregnant women. Senior clinicians and policy makers were consulted to understand the determinants of VPA use. Results At least one VPA prescription was dispensed to between 8205 (0.79%) and 9425 (0.94%) WOBCA from a cohort of approximately 1 million WOCBA attending provincial health care facilities per year. Prescriptions were more likely in HIV-infected women compared with HIV-uninfected women (1.1–1.3% vs. 0.7–0.9%; p
Suggested Citation
Ushma Mehta & Mariette Smith & Emma Kalk & Helen Hayes & Annoesjka Swart & Lawrence Tucker & Renier Coetzee & Andrew Boulle & Marc Blockman, 2021.
"Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa,"
Drug Safety, Springer, vol. 44(1), pages 41-51, January.
Handle:
RePEc:spr:drugsa:v:44:y:2021:i:1:d:10.1007_s40264-020-00987-4
DOI: 10.1007/s40264-020-00987-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:44:y:2021:i:1:d:10.1007_s40264-020-00987-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.